Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 15(8): 829-40, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24954781
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Ducts
/
Pancreatic Neoplasms
/
Peptide Fragments
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Telomerase
/
Cancer Vaccines
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2014
Document type:
Article
Affiliation country:
United kingdom